Hui Fu Selected Research

Breast Neoplasms (Breast Cancer)

5/2024	Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.
4/2020	Factors Affecting Pathological Complete Response After Neoadjuvant Chemotherapy in Operable Primary Breast Cancer.
8/2019	Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
2/2017	miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
1/2017	cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
1/2015	Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
1/2013	Association between Gαi2 and ELMO1/Dock180 connects chemokine signalling with Rac activation and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Fu Research Topics

Disease

19	Inflammation (Inflammations) 04/2024 - 01/2015
19	Neoplasms (Cancer) 01/2023 - 01/2013
12	Fibrosis (Cirrhosis) 04/2024 - 01/2018
9	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2013
8	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 02/2015
8	Heart Failure 03/2024 - 10/2019
8	Body Weight (Weight, Body) 01/2024 - 02/2010
7	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2013
7	Pain (Aches) 01/2024 - 01/2006
6	Atrial Fibrillation 01/2024 - 01/2020
4	Obesity 02/2024 - 01/2019
4	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2021
4	Infections 01/2024 - 01/2020
4	Demyelinating Diseases (Demyelinating Disease) 04/2023 - 04/2012
4	Cardiac Arrhythmias (Arrythmia) 02/2023 - 06/2012
4	Vascular System Injuries 10/2022 - 01/2018
4	COVID-19 01/2022 - 01/2020
3	Hypertrophy 04/2024 - 01/2004
3	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2018
3	Airway Remodeling 11/2017 - 09/2014
3	Vascular Diseases (Vascular Disease) 01/2017 - 10/2014
3	Ischemia 11/2016 - 08/2012
2	Hypersensitivity (Allergy) 05/2024 - 05/2017
2	Parkinson Disease (Parkinson's Disease) 04/2024 - 10/2018
2	Abdominal Aortic Aneurysm 10/2023 - 10/2022
2	Atrial Remodeling 09/2023 - 02/2019
2	Triple Negative Breast Neoplasms 11/2022 - 10/2022
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
2	Carcinogenesis 01/2022 - 01/2017
2	Necrosis 01/2022 - 03/2019
2	Myocardial Infarction 06/2021 - 10/2019
2	Infarction (Infarctions) 06/2021 - 02/2019
2	Memory Disorders (Memory Loss) 01/2021 - 03/2011
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 10/2019
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020 - 01/2004
2	Sepsis (Septicemia) 01/2019 - 01/2014
2	Hypertension (High Blood Pressure) 01/2018 - 01/2016
2	Asthma (Bronchial Asthma) 11/2017 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 07/2017 - 06/2015
2	Hyperalgesia 05/2017 - 12/2004
2	Pathologic Processes 01/2016 - 12/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2015 - 07/2014
2	Hypoxia (Hypoxemia) 03/2014 - 02/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2023 - 04/2012
6	Interleukin-6 (Interleukin 6)IBA 12/2022 - 04/2016
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2022 - 01/2016
5	CytokinesIBA 10/2024 - 04/2016
5	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 11/2023 - 01/2019
4	LipidsIBA 01/2024 - 01/2019
4	InflammasomesIBA 11/2023 - 09/2020
4	MD1IBA 06/2021 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 06/2012
3	LipopolysaccharidesIBA 12/2022 - 01/2019
3	VaccinesIBA 01/2022 - 01/2020
3	ChemokinesIBA 01/2022 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 10/2019 - 02/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 04/2016
3	OvalbuminIBA 11/2017 - 09/2014
3	FlavonoidsIBA 08/2012 - 01/2011
2	Trastuzumab (Herceptin)FDA Link 05/2024 - 04/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 02/2022
2	phenylacetylglutamineIBA 01/2024 - 03/2023
2	CollagenIBA 10/2023 - 09/2014
2	Oxygen (Dioxygen)IBA 09/2023 - 06/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 09/2023 - 01/2020
2	phospholambanIBA 09/2023 - 01/2020
2	sodium-calcium exchanger 1IBA 09/2023 - 01/2020
2	CalciumIBA 09/2023 - 01/2020
2	dapagliflozinIBA 02/2023 - 01/2021
2	AntigensIBA 10/2022 - 01/2022
2	Angiotensin IIIBA 02/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2022
2	NitrogenIBA 01/2022 - 01/2022
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 01/2021
2	Long Noncoding RNAIBA 01/2022 - 10/2017
2	BIBP COVID-19 vaccineIBA 01/2022 - 01/2020
2	Ion Channels (Ion Channel)IBA 06/2021 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 03/2019
2	Casein Kinase II (Casein Kinase 2)IBA 01/2021 - 01/2019
2	Superoxide DismutaseIBA 01/2021 - 01/2018
2	CurcuminIBA 12/2020 - 05/2017
2	Arginine (L-Arginine)FDA Link 01/2020 - 08/2019
2	Analgesics (Analgesic Drugs)IBA 01/2020 - 02/2016
2	MicroRNAs (MicroRNA)IBA 10/2019 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2019 - 08/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2004
2	Apolipoproteins E (ApoE)IBA 01/2019 - 10/2018
2	CholesterolIBA 01/2019 - 01/2018
2	PNU-282987IBA 01/2018 - 01/2018
2	SaltsIBA 01/2018 - 01/2018
2	Phospholipases (Phospholipase)IBA 10/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 05/2017 - 02/2016
2	Acid Sensing Ion ChannelsIBA 02/2016 - 12/2010

Therapy/Procedure

15	Therapeutics 05/2024 - 04/2016
3	Ligation 06/2021 - 01/2004
2	Immunotherapy 01/2023 - 10/2022
2	Aftercare (After-Treatment) 02/2022 - 02/2022
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 08/2018
2	Drug Therapy (Chemotherapy) 04/2020 - 10/2014